European population is ageing rapidly and chronic diseases are burdening the European healthcare system driving up health care costs. Point of Care solutions, personalized medicine, patient monitoring and home testing are trends in the medical fields expected to support the necessary evolution of healthcare systems. Precision medicine is indeed emerging. It can be defined as tailored treatment programs designed to maximise beneficial health outcomes and reduce the non-adherence with prescribed medicines.

"The revolution in mobile communication, diagnostics and advanced sensor technology undoubtedly has a role to play and will enable provision of a highly customised intervention for individual patients." (Source: Innovative Medical Initiative Strategic Digital Agenda)

The evolution of the health industry represents a real business opportunity for European SMEs ready to invest in smart technologies. The gateone-project will support European SMEs to test innovative technologies through our free demonstrators evaluation program.

The gateone-project is dedicated to support European SMEs to benefit from this market opportunity in selecting the right technologies to adapt and adopt. The gateone-project is offering to European SMEs a free evaluation program of demonstrators developed by leading European research centers.

Indeed invited experts will share 4 key success factors to develop business:

1 – Trends and needs in the pharmaceutical industry and healthcare systems by IMI “Innovative Medicines Initiative”

2 – Available solutions to be tested under gateone-project free evaluation program

• New R&D approach for biomarkers identification
• Accurate and precise administration of drugs
• Specific focus on diagnostics, sensors and imaging technologies.

3 – Review of main regulatory challenges to consider all along product development by Voisin Consulting Life Sciences

Adressing the pharmaceutical industry requires an in-depth understanding of regulatory constraints, Voisin Consulting Life Sciences will share good to know to be ready to enter this market.

4 – Beyond gateone-project: collaborative projects opportunities to support innovation for European SMEs by IMI “Innovative Medicines Initiative”

To register to gateone-project webinar, click here or go to the address https://attendee.gotowebinar.com/register/8623485456587806722

Contact: Régis Hamelin, Scientific Coordinator of gateone project

E-mail: hamelin@bmorpho.com

Project ID: 644856 - H2020-ICT-2014-1

Gateone is an Innovation Action between:

BLUMORPHO, CEA-LETI , CSEM, Tyndall National Institute, Teesside University, LAAS CNRS, Fraunhofer IPMS , IK4-Ikerlan and VTT Technical Research Centre of Finland Ltd.

More information: www.gateone-project.eu.